Lipiodol

Overview

WikiDoc Resources for Lipiodol
Articles
Most recent articles on Lipiodol Most cited articles on Lipiodol Review articles on Lipiodol Articles on Lipiodol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Lipiodol Images of Lipiodol Photos of Lipiodol Podcasts & MP3s on Lipiodol Videos on Lipiodol
Evidence Based Medicine
Cochrane Collaboration on Lipiodol Bandolier on Lipiodol TRIP on Lipiodol
Clinical Trials
Ongoing Trials on Lipiodol at Clinical Trials.gov Trial results on Lipiodol Clinical Trials on Lipiodol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Lipiodol NICE Guidance on Lipiodol NHS PRODIGY Guidance FDA on Lipiodol CDC on Lipiodol
Books
Books on Lipiodol
News
Lipiodol in the news Be alerted to news on Lipiodol News trends on Lipiodol
Commentary
Blogs on Lipiodol
Definitions
Definitions of Lipiodol
Patient Resources / Community
Patient resources on Lipiodol Discussion groups on Lipiodol Patient Handouts on Lipiodol Directions to Hospitals Treating Lipiodol Risk calculators and risk factors for Lipiodol
Healthcare Provider Resources
Symptoms of Lipiodol Causes & Risk Factors for Lipiodol Diagnostic studies for Lipiodol Treatment of Lipiodol
Continuing Medical Education (CME)
CME Programs on Lipiodol
International
Lipiodol en Espanol Lipiodol en Francais
Business
Lipiodol in the Marketplace Patents on Lipiodol
Experimental / Informatics
List of terms related to Lipiodol

Lipiodol is an iodinated, radio-opaque contrast material that is used to outline structures in radiological investigations.

It is used in chemoembolization applications as a contrast agent in follow-up imaging. It has an additional use in gastric variceal obliteration as a dilutant that does not affect polymerization of cyanoacrylate.

Lipiodol is also used in lymphangiography, the imaging of the lymphatic system.

Historically it was often used as a contrast media at hysterosalpingography(HSG). This is an investigation to determine tubal patency as part of the investigation of subfertility. It became less commonly utilised in the 1960s to 1980s because the more modern water soluble media give images that are easier to interpret. There is also an important safety issue with lipiodol in that intravasation (leakage) of the fluid into the venous system has caused patients to be uwell in the past because of intravasation.

Recently there has been an increasing interest in the use of lipiodol as a therapeutic agent in the management of unexplained infertility called lipiodol flushing. There have been a small number of studies that suggest that flushing the media through the tubes gives a short term rise in fecundity in patients with unexplained infertility. A recent systematic review has suggested a significant increase in fertility, especially in those women who have endometriosis when using lipiodol flushing (Johnson N.P et al).